Largest Biotechnology Companies by Market Cap
Largest Biotechnology companies by market cap. The Biotechnology sector has 1,295 publicly listed stocks with a combined market cap of $2.06 Trillion. Cambium Bio Ltd leads the sector with a market cap of $7.74 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
Companies Listed
Largest Company
Top Biotechnology Stocks by Market Capitalization (November 2026)
Top Biotechnology stocks by market capitalization as of November 2026, covering 1,295 publicly listed companies.
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1051 |
Cambium Bio Ltd
AU:CMB |
$7.74 Million | AU$10.93 Million | Australia | AU$0.40 | -4.76% | -11.11% | 7.86K |
| 1052 |
Alzinova AB
ST:ALZ |
$7.73 Million | Skr71.84 Million | Sweden | Skr0.35 | -5.59% | -16.69% | 59.31 Million |
| 1053 |
Pila Pharma AB
ST:PILA |
$7.67 Million | Skr71.26 Million | Sweden | Skr1.56 | -0.32% | -0.64% | 762.23K |
| 1054 |
Synlogic Inc
NASDAQ:SYBX |
$7.49 Million | $7.49 Million | USA | $1.17 | -4.10% | -4.10% | 555.65K |
| 1055 |
VistaGen Therapeutics Inc
NASDAQ:VTGN |
$7.47 Million | $7.47 Million | USA | $0.17 | -1.41% | -10.00% | 24.81 Million |
| 1056 |
MetaVia Inc.
NASDAQ:MTVA |
$7.38 Million | $7.38 Million | USA | $1.12 | -5.88% | -19.42% | 1.58 Million |
| 1057 |
Lexaria Bioscience Corp
NASDAQ:LEXX |
$7.35 Million | $7.35 Million | USA | $3.49 | -7.43% | +16.72% | 1.40 Million |
| 1058 |
TME Pharma N.V.
PA:ALTME |
$7.34 Million | €6.28 Million | France | €0.12 | -11.30% | +12.32% | 39.30 Million |
| 1059 |
AcouSort AB
ST:ACOU |
$7.33 Million | Skr68.15 Million | Sweden | Skr3.22 | +0.94% | -6.67% | 1.20 Million |
| 1060 |
CNS Pharmaceuticals Inc
NASDAQ:CNSP |
$7.31 Million | $7.31 Million | USA | $5.00 | +4.82% | +5.26% | 328.77K |
| 1061 |
Akari Therapeutics PLC
NASDAQ:AKTX |
$7.15 Million | $7.15 Million | USA | $8.24 | +3.00% | +1.73% | 1.06 Million |
| 1062 |
ProMIS Neurosciences Inc.
NASDAQ:PMN |
$7.12 Million | $7.12 Million | USA | $3.31 | -70.13% | -63.14% | 2.28 Million |
| 1063 |
BioLight Life Sciences Ltd
TA:BOLT |
$7.08 Million | ILA2.64 Billion | Israel | ILA292.00 | -7.89% | -4.54% | 180.45K |
| 1064 |
Kiora Pharmaceuticals Inc
NASDAQ:KPRX |
$6.90 Million | $6.90 Million | USA | $1.56 | -11.36% | -32.76% | 921.74K |
| 1065 |
TNF Pharmaceuticals, Inc.
NASDAQ:TNFA |
$6.80 Million | $6.80 Million | USA | $3.68 | +0.00% | +0.00% | 607.33K |
| 1066 |
NFL Biosciences SAS
PA:ALNFL |
$6.67 Million | €5.70 Million | France | €0.45 | +12.22% | -19.64% | 1.59 Million |
| 1067 |
Exicure Inc
NASDAQ:XCUR |
$6.55 Million | $6.55 Million | USA | $1.01 | +8.04% | -10.62% | 1.29 Million |
| 1068 |
OSR Holdings Inc
NASDAQ:OSRH |
$6.50 Million | $6.50 Million | USA | $0.19 | -7.86% | -24.41% | 589.78 Million |
| 1069 |
Immuron Ltd ADR
NASDAQ:IMRN |
$6.45 Million | $6.45 Million | USA | $0.88 | +0.40% | +6.82% | 689.90K |
| 1070 |
Curative Biotechnology Inc
NYSE MKT:CUBT |
$6.36 Million | $6.36 Million | USA | $0.83 | +0.00% | -7.79% | 22.50K |
| 1071 |
Processa Pharmaceuticals Inc
NASDAQ:PCSA |
$6.34 Million | $6.34 Million | USA | $1.89 | +0.00% | +1.61% | 4.04 Million |
| 1072 |
Reviva Pharmaceuticals Holdings Inc.
NASDAQ:RVPH |
$6.29 Million | $6.29 Million | USA | $0.48 | -10.26% | -11.11% | 520.01K |
| 1073 |
Can Fite Biopharma Ltd ADR
NYSE MKT:CANF |
$6.23 Million | $6.23 Million | USA | $2.91 | -1.69% | -8.20% | 734.49K |
| 1074 |
Titan Pharmaceuticals Inc
NASDAQ:TTNP |
$6.13 Million | $6.13 Million | USA | $4.61 | +0.00% | +0.00% | 0.00 |
| 1075 |
Aprea Therapeutics Inc
NASDAQ:APRE |
$6.10 Million | $6.10 Million | USA | $0.48 | -1.82% | -10.52% | 6.50 Million |
| 1076 |
Alzamend Neuro Inc
NASDAQ:ALZN |
$5.84 Million | $5.84 Million | USA | $1.21 | -0.82% | +8.04% | 810.38K |
| 1077 |
Nanologica AB
ST:NICA |
$5.84 Million | Skr54.25 Million | Sweden | Skr0.17 | -2.94% | -34.00% | 16.56 Million |
| 1078 |
BRITANNIA LIFE SCIENCES
F:L020 |
$5.69 Million | €4.87 Million | Germany | €0.03 | +0.00% | +15.38% | 0.00 |
| 1079 |
Skye Bioscience, Inc. Common Stock
NASDAQ:SKYE |
$5.67 Million | $5.67 Million | USA | $1.28 | -2.29% | -20.99% | 665.60K |
| 1080 |
Clearmind Medicine Inc. Common Shares
NASDAQ:CMND |
$5.61 Million | $5.61 Million | USA | $6.22 | +6.31% | +3.65% | 831.02K |
| 1081 |
COLLPLANT BIOTECH. IS-01
F:CPT |
$5.48 Million | €4.69 Million | Germany | €3.78 | +11.83% | +19.62% | 229.00 |
| 1082 |
BetterLife Pharma Inc
F:NPAU |
$5.42 Million | €4.64 Million | Germany | €0.07 | +104.55% | +117.74% | 1.02K |
| 1083 |
INVEX Therapeutics Ltd
AU:IXC |
$5.32 Million | AU$7.52 Million | Australia | AU$0.10 | +0.00% | -4.76% | 1.07 Million |
| 1084 |
Combigene AB
ST:COMBI |
$5.24 Million | Skr48.71 Million | Sweden | Skr2.46 | +0.00% | +0.00% | 14.23K |
| 1085 |
Niki BioSolutions, Inc.
NASDAQ:NIKI |
$5.20 Million | $5.20 Million | USA | $1.77 | -9.51% | -4.84% | 324.68K |
| 1086 |
Annexin Pharmaceuticals AB
ST:ANNX |
$5.12 Million | Skr47.58 Million | Sweden | Skr6.64 | -0.90% | -15.09% | 157.03K |
| 1087 |
Pulmatrix Inc
NASDAQ:PULM |
$5.11 Million | $5.11 Million | USA | $1.40 | -1.06% | -1.41% | 497.99K |
| 1088 |
Cellectar Biosciences Inc
NASDAQ:CLRB |
$5.11 Million | $5.11 Million | USA | $1.21 | -1.23% | +2.99% | 3.80 Million |
| 1089 |
Imunon Inc
NASDAQ:IMNN |
$5.11 Million | $5.11 Million | USA | $0.91 | +9.24% | -27.20% | 2.92 Million |
| 1090 |
ONCODES.PREC.MED. EO-34
F:ZR8 |
$5.08 Million | €4.35 Million | Germany | €0.23 | +1.33% | -25.00% | 0.00 |
| 1091 |
Marvel Biosciences Corp
V:MRVL |
$5.04 Million | CA$6.96 Million | Canada | CA$0.12 | +0.00% | +4.35% | 2.32 Million |
| 1092 |
Quantum Genomics SA
PA:ALQGC |
$5.03 Million | €4.30 Million | France | €0.07 | +0.00% | +0.00% | 0.00 |
| 1093 |
Cardio Diagnostics Holdings Inc
NASDAQ:CDIO |
$4.94 Million | $4.94 Million | USA | $1.67 | -4.57% | -2.05% | 610.26K |
| 1094 |
Bio Green Med Solution, Inc.
NASDAQ:BGMS |
$4.86 Million | $4.86 Million | USA | $0.90 | +8.43% | -4.64% | 709.10K |
| 1095 |
Purple Biotech Ltd
TA:PPBT |
$4.84 Million | ILA1.81 Billion | Israel | ILA1.00 | +0.00% | +0.00% | 350.00K |
| 1096 |
Salarius Pharmaceuticals Inc
NASDAQ:SLRX |
$4.81 Million | $4.81 Million | USA | $0.82 | -2.40% | +26.59% | 14.81 Million |
| 1097 |
Xenetic Biosciences Inc
NASDAQ:XBIO |
$4.80 Million | $4.80 Million | USA | $2.05 | -3.30% | +6.22% | 607.80K |
| 1098 |
Plant Advanced Technologies SA
PA:ALPAT |
$4.74 Million | €4.06 Million | France | €3.56 | -4.81% | -9.64% | 4.45K |
| 1099 |
Qualigen Therapeutics Inc
NASDAQ:QLGN |
$4.74 Million | $4.74 Million | USA | $2.33 | +0.30% | -8.98% | 2.43 Million |
| 1100 |
Oncozenge AB
ST:ONCOZ |
$4.70 Million | Skr43.69 Million | Sweden | Skr3.11 | -2.51% | -5.61% | 1.43 Million |
| 1101 |
Exact Therapeutics AS
OL:EXTX |
$4.66 Million | Nkr44.28 Million | Norway | Nkr0.70 | +40.56% | +7.69% | 3.16 Million |
| 1102 |
Zelira Therapeutics Ltd
AU:ZLD |
$4.65 Million | AU$6.57 Million | Australia | AU$0.50 | +0.00% | +0.00% | 0.00 |
| 1103 |
Propanc Biopharma, Inc. Common Stock
NASDAQ:PPCB |
$4.63 Million | $4.63 Million | USA | $1.84 | -12.80% | +571.53% | 6.65 Million |
| 1104 |
Pure Biologics Spólka Akcyjna
WAR:PUR |
$4.61 Million | zł16.75 Million | Poland | zł1.48 | +6.95% | -0.40% | 7.81 Million |
| 1105 |
Traws Pharma Inc
NASDAQ:TRAW |
$4.55 Million | $4.55 Million | USA | $0.30 | -1.66% | -19.28% | 4.61 Million |
| 1106 |
Acurx Pharmaceuticals LLC
NASDAQ:ACXP |
$4.47 Million | $4.47 Million | USA | $1.04 | -2.80% | -8.77% | 1.82 Million |
| 1107 |
Aptose Biosciences Inc
TO:APS |
$4.43 Million | CA$6.13 Million | Canada | CA$2.40 | +0.00% | +9.09% | 85.56K |
| 1108 |
Senti Biosciences Inc
NASDAQ:SNTI |
$4.34 Million | $4.34 Million | USA | $0.17 | -23.92% | -13.33% | 90.06 Million |
| 1109 |
Creative Medical Technology Holdings Inc
NASDAQ:CELZ |
$4.32 Million | $4.32 Million | USA | $0.66 | -3.45% | -15.37% | 2.60 Million |
| 1110 |
DMD Digital Health Connections Group Inc
NASDAQ:APTOF |
$4.31 Million | $4.31 Million | USA | $1.69 | +0.00% | +9.03% | 52.70K |
| 1111 |
CASI Pharmaceuticals Inc
NASDAQ:CASI |
$4.26 Million | $4.26 Million | USA | $0.24 | +17.06% | -68.82% | 11.66 Million |
| 1112 |
NuCana PLC
NASDAQ:NCNA |
$4.20 Million | $4.20 Million | USA | $1.01 | -2.88% | +5.21% | 3.28 Million |
| 1113 |
Biophytis S.A.
NASDAQ:BPTSY |
$4.19 Million | $4.19 Million | USA | $2.08 | +0.00% | +0.00% | 0.00 |
| 1114 |
Inhalerx Ltd
AU:IRX |
$4.18 Million | AU$5.91 Million | Australia | AU$0.02 | +4.35% | +33.33% | 1.37 Million |
| 1115 |
Fluicell AB
ST:FLUI |
$4.12 Million | Skr38.33 Million | Sweden | Skr27.90 | +0.72% | +5.28% | 53.03K |
| 1116 |
Kineta, Inc.
NASDAQ:KANT |
$4.12 Million | $4.12 Million | USA | $0.34 | +0.00% | +0.00% | 0.00 |
| 1117 |
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD |
$4.10 Million | $4.10 Million | USA | $3.84 | -6.11% | -6.77% | 2.50 Million |
| 1118 |
Matinas BioPharma Holdings Inc
NYSE MKT:MTNB |
$4.09 Million | $4.09 Million | USA | $0.70 | +5.09% | +23.06% | 7.31 Million |
| 1119 |
Tissue Repair Ltd
AU:TRP |
$4.06 Million | AU$5.74 Million | Australia | AU$0.10 | +0.00% | +14.46% | 796.32K |
| 1120 |
International Biotechnology Trust plc
LSE:IBT |
$4.04 Million | GBX33.18 Billion | UK | GBX1040.00 | +0.00% | +0.00% | 1.51 Million |
| 1121 |
Revelation Biosciences Inc
NASDAQ:REVB |
$4.02 Million | $4.02 Million | USA | $4.03 | +7.47% | +9.51% | 1.76 Million |
| 1122 |
NLS Pharmaceutics AG
NASDAQ:NLSP |
$3.97 Million | $3.97 Million | USA | $0.76 | +0.00% | +0.00% | 7.12 Million |
| 1123 |
Kane Biotech Inc
V:KNE |
$3.95 Million | CA$5.46 Million | Canada | CA$0.03 | -14.29% | +0.00% | 1.46 Million |
| 1124 |
Biotron Ltd
AU:BIT |
$3.94 Million | AU$5.57 Million | Australia | AU$0.00 | +0.00% | +0.00% | 71.48 Million |
| 1125 |
Addex Therapeutics Ltd
NASDAQ:ADXN |
$3.91 Million | $3.91 Million | USA | $3.09 | +5.46% | +6.84% | 176.96K |
| 1126 |
Addex Therapeutics Ltd
SW:ADXN |
$3.89 Million | CHF3.08 Million | Switzerland | CHF0.02 | +9.71% | +0.00% | 12.13 Million |
| 1127 |
Liminatus Pharma, Inc. Class A Common Stock
NASDAQ:LIMN |
$3.79 Million | $3.79 Million | USA | $2.82 | -2.59% | -9.32% | 608.22K |
| 1128 |
BIOVAXYS TECHNOLOGY CORP.
F:5LB |
$3.75 Million | €3.20 Million | Germany | €0.15 | +0.00% | +0.00% | 0.00 |
| 1129 |
GLOW LIFETECH CORP.
F:9DO |
$3.66 Million | €3.13 Million | Germany | €0.02 | +2.13% | +2.13% | 0.00 |
| 1130 |
Adalta Ltd
AU:1AD |
$3.61 Million | AU$5.10 Million | Australia | AU$0.00 | -33.33% | -33.33% | 100.28 Million |
| 1131 |
XORTX Therapeutics Inc
V:XRTX |
$3.55 Million | CA$4.91 Million | Canada | CA$3.19 | +4.59% | +13.93% | 24.13K |
| 1132 |
Modus Therapeutics Holding AB
ST:MODTX |
$3.49 Million | Skr32.43 Million | Sweden | Skr0.18 | +1.37% | +2.50% | 28.01 Million |
| 1133 |
GRI Bio Inc.
NASDAQ:GRI |
$3.34 Million | $3.34 Million | USA | $1.53 | -2.55% | +7.75% | 875.72K |
| 1134 |
PreveCeutical Medical Inc
F:18H |
$3.34 Million | €2.85 Million | Germany | €0.01 | -54.55% | -77.27% | 300.00K |
| 1135 |
BIOMIND LABS INC.
F:3XI |
$3.31 Million | €2.83 Million | Germany | €0.04 | +0.00% | -30.48% | 10.50K |
| 1136 |
XTL Biopharmaceuticals Ltd
TA:XTLB |
$3.31 Million | ILA1.23 Billion | Israel | ILA1.40 | +0.00% | -12.50% | 18.88 Million |
| 1137 |
60 Degrees Pharmaceuticals, Inc. Common Stock
NASDAQ:SXTP |
$3.31 Million | $3.31 Million | USA | $0.94 | -0.79% | +7.32% | 22.92 Million |
| 1138 |
Azitra Inc
NYSE MKT:AZTR |
$3.30 Million | $3.30 Million | USA | $0.20 | -3.77% | +10.57% | 13.26 Million |
| 1139 |
PharmaCyte Biotech Inc
NASDAQ:PMCB |
$3.24 Million | $3.24 Million | USA | $0.30 | -9.03% | -13.69% | 1.89 Million |
| 1140 |
Avacta Group PLC
LSE:AVCT |
$3.22 Million | GBX26.48 Billion | UK | GBX60.50 | -0.82% | -5.62% | 40.72 Million |
| 1141 |
Iterum Therapeutics PLC
NASDAQ:ITRM |
$3.20 Million | $3.20 Million | USA | $0.06 | -12.01% | +9.27% | 3.77 Million |
| 1142 |
Guard Therapeutics International AB
ST:GUARD |
$3.19 Million | Skr29.61 Million | Sweden | Skr1.47 | +1.24% | +10.54% | 446.11K |
| 1143 |
Psyence Biomedical Ltd. Common Shares
NASDAQ:PBM |
$3.16 Million | $3.16 Million | USA | $3.31 | -8.31% | -19.66% | 1.23 Million |
| 1144 |
Jaguar Animal Health Inc
NASDAQ:JAGX |
$3.15 Million | $3.15 Million | USA | $1.62 | -20.59% | -24.65% | 62.75 Million |
| 1145 |
Bioleaders Corporation
KQ:142760 |
$3.14 Million | ₩4.64 Billion | Korea | ₩220.00 | -6.78% | -54.83% | 29.42 Million |
| 1146 |
Dermata Therapeutics Inc
NASDAQ:DRMA |
$3.12 Million | $3.12 Million | USA | $0.78 | -7.86% | -10.30% | 173.65 Million |
| 1147 |
Kala Pharmaceuticals Inc
NASDAQ:KALA |
$3.08 Million | $3.08 Million | USA | $0.17 | -5.48% | -10.78% | 78.82 Million |
| 1148 |
ValiRx plc
LSE:VAL |
$3.05 Million | £2.27 Million | UK | £0.17 | +0.00% | +21.43% | 727.40 Million |
| 1149 |
Bio-Gene Technology Ltd
AU:BGT |
$3.02 Million | AU$4.27 Million | Australia | AU$0.01 | +7.69% | +0.00% | 6.31 Million |
| 1150 |
Can Fite Biopharma Ltd
TA:CANF |
$2.95 Million | ILA1.10 Billion | Israel | ILA257.00 | -4.60% | -15.90% | 323.07K |
| 1151 |
Opthea Limited
NASDAQ:OPTEY |
$2.94 Million | $2.94 Million | USA | $0.02 | +0.00% | -22.17% | 358.37K |
| 1152 |
ACRUX Ltd
AU:ACR |
$2.91 Million | AU$4.11 Million | Australia | AU$0.01 | +0.00% | -9.09% | 20.58 Million |
| 1153 |
LOBE SCIENCES LTD
F:6YX0 |
$2.90 Million | €2.48 Million | Germany | €0.03 | +0.00% | +0.00% | 0.00 |
| 1154 |
Spago Nanomedical AB
ST:SPAGO |
$2.86 Million | Skr26.60 Million | Sweden | Skr0.04 | +0.50% | -61.35% | 46.23 Million |
| 1155 |
Vectus Biosystems Ltd
AU:VBS |
$2.84 Million | AU$4.01 Million | Australia | AU$0.08 | -5.06% | -16.67% | 996.12K |
| 1156 |
Rakovina Therapeutics Inc
V:RKV |
$2.83 Million | CA$3.91 Million | Canada | CA$0.19 | -2.63% | +15.62% | 350.93K |
| 1157 |
Green Cross Holdings Preference Shares
KO:005257 |
$2.77 Million | ₩4.09 Billion | Korea | ₩16980.00 | +0.00% | +1.49% | 2.89K |
| 1158 |
LakeShore Biopharma Co., Ltd
NYSE:LSBCF |
$2.76 Million | $2.76 Million | USA | $0.07 | +0.00% | +0.00% | 55.20K |
| 1159 |
NextCell Pharma AB
ST:NXTCL |
$2.76 Million | Skr25.62 Million | Sweden | Skr0.23 | -13.21% | -76.88% | 26.63 Million |
| 1160 |
Unity Biotechnology Inc
NASDAQ:UBX |
$2.75 Million | $2.75 Million | USA | $0.16 | +0.00% | +0.00% | 1.42 Million |
| 1161 |
Jupiter Neurosciences, Inc. Common Stock
NASDAQ:JUNS |
$2.70 Million | $2.70 Million | USA | $2.05 | -13.50% | -20.54% | 1.43 Million |
| 1162 |
Mustang Bio Inc
NASDAQ:MBIO |
$2.69 Million | $2.69 Million | USA | $0.40 | +1.94% | +8.37% | 945.49K |
| 1163 |
Omega Therapeutics Inc
NASDAQ:OMGA |
$2.69 Million | $2.69 Million | USA | $0.05 | +0.00% | +0.00% | 105.64K |
| 1164 |
Calidi Biotherapeutics Inc.
NYSE MKT:CLDI |
$2.68 Million | $2.68 Million | USA | $0.18 | -8.29% | -7.32% | 212.03 Million |
| 1165 |
Evogene
TA:EVGN |
$2.68 Million | ILA998.23 Million | Israel | ILA114.50 | -2.80% | -1.63% | 2.51 Million |
| 1166 |
Innovotech Inc
V:IOT |
$2.56 Million | CA$3.54 Million | Canada | CA$0.07 | -7.14% | -7.14% | 821.64K |
| 1167 |
Silo Pharma Inc
NASDAQ:SILO |
$2.53 Million | $2.53 Million | USA | $1.23 | -1.60% | +4.24% | 2.08 Million |
| 1168 |
Palatin Technologies Inc
NYSE MKT:PTN |
$2.45 Million | $2.45 Million | USA | $23.00 | +4.59% | +0.00% | 243.66K |
| 1169 |
Quest PharmaTech Inc
V:QPT |
$2.45 Million | CA$3.38 Million | Canada | CA$0.02 | +0.00% | -33.33% | 659.45K |
| 1170 |
Bioatla Inc
NASDAQ:BCAB |
$2.44 Million | $2.44 Million | USA | $1.47 | -2.00% | +13.08% | 2.74 Million |
| 1171 |
Aptevo Therapeutics Inc
NASDAQ:APVO |
$2.43 Million | $2.43 Million | USA | $1.34 | -1.47% | -16.77% | 955.87K |
| 1172 |
Oragenics Inc
NYSE MKT:OGEN |
$2.42 Million | $2.42 Million | USA | $0.60 | +1.69% | +5.13% | 1.11 Million |
| 1173 |
Eterna Therapeutics Inc
NASDAQ:ERNA |
$2.30 Million | $2.30 Million | USA | $1.97 | -6.64% | -5.06% | 1.46 Million |
| 1174 |
Alaunos Therapeutics Inc
NASDAQ:TCRT |
$2.29 Million | $2.29 Million | USA | $1.95 | +3.17% | -35.86% | 420.30 Million |
| 1175 |
Cyclerion Therapeutics Inc
NASDAQ:CYCN |
$2.25 Million | $2.25 Million | USA | $23.94 | +463.29% | +500.00% | 1.48 Million |
| 1176 |
Biodexa Pharmaceticals
NASDAQ:BDRX |
$2.22 Million | $2.22 Million | USA | $3.43 | -12.05% | +728.50% | 72.39 Million |
| 1177 |
Clearside Biomedical Inc
NASDAQ:CLSD |
$2.15 Million | $2.15 Million | USA | $0.41 | -26.96% | -85.66% | 12.36 Million |
| 1178 |
Elevai Labs, Inc. Common Stock
NASDAQ:ELAB |
$2.10 Million | $2.10 Million | USA | $2.60 | -1.52% | -2.26% | 662.61K |
| 1179 |
VivoSim Labs, Inc.
NASDAQ:VIVS |
$2.07 Million | $2.07 Million | USA | $0.15 | -1.97% | -3.01% | 20.66 Million |
| 1180 |
HCW Biologics Inc
NASDAQ:HCWB |
$2.02 Million | $2.02 Million | USA | $1.10 | -6.78% | -1.79% | 3.38 Million |
| 1181 |
Cynata Therapeutics Ltd
AU:CYP |
$2.02 Million | AU$2.85 Million | Australia | AU$0.01 | +0.00% | +9.09% | 19.37 Million |
| 1182 |
Abpro Holdings, Inc.
NYSE:ABP |
$2.00 Million | $2.00 Million | USA | $6.15 | -0.81% | +0.82% | 230.50K |
| 1183 |
Aditxt Inc.
NASDAQ:ADTX |
$2.00 Million | $2.00 Million | USA | $0.01 | -12.82% | -5.56% | 674.47 Million |
| 1184 |
Kancera AB (publ)
ST:KAN |
$1.98 Million | Skr18.44 Million | Sweden | Skr0.15 | -23.82% | +0.00% | 2.30 Million |
| 1185 |
PALATIN TECHS DL-01
F:PTN |
$1.97 Million | €1.68 Million | Germany | €3.30 | +0.00% | +0.00% | 0.00 |
| 1186 |
Medigene AG
XETRA:MDG1 |
$1.97 Million | €1.68 Million | Germany | €0.13 | +0.00% | +0.00% | 189.47K |
| 1187 |
Plantarc Bio Ltd
TA:PLNT |
$1.96 Million | ILA731.02 Million | Israel | ILA220.90 | +0.00% | +1.33% | 217.47K |
| 1188 |
Purple Biotech
NASDAQ:PPBT |
$1.90 Million | $1.90 Million | USA | $1.17 | +7.34% | +11.43% | 553.39K |
| 1189 |
Prostemics Co. Ltd
KQ:203690 |
$1.88 Million | ₩2.78 Billion | Korea | ₩139.00 | +0.00% | +0.00% | 3.45 Million |
| 1190 |
Genprex Inc
NASDAQ:GNPX |
$1.84 Million | $1.84 Million | USA | $2.24 | +9.80% | +13.13% | 4.26 Million |
| 1191 |
Medesis Pharma SA
PA:ALMDP |
$1.80 Million | €1.54 Million | France | €0.35 | +0.00% | +0.00% | 0.00 |
| 1192 |
Transcode Therapeutics Inc
NASDAQ:RNAZ |
$1.73 Million | $1.73 Million | USA | $1.63 | -5.78% | -4.96% | 762.83K |
| 1193 |
Hepion Pharmaceuticals Inc
NASDAQ:HEPA |
$1.66 Million | $1.66 Million | USA | $0.06 | -11.97% | -8.09% | 600.68K |
| 1194 |
BioSenic S.A.
BR:BIOS |
$1.57 Million | €1.34 Million | Belgium | €0.00 | +0.00% | +0.00% | 3.25 Million |
| 1195 |
Oncternal Therapeutics Inc
NASDAQ:ONCT |
$1.56 Million | $1.56 Million | USA | $0.53 | +0.00% | +0.00% | 0.00 |
| 1196 |
GEMINA LABS LTD
F:8I7 |
$1.53 Million | €1.31 Million | Germany | €0.02 | +0.00% | -16.28% | 4.50K |
| 1197 |
Biophytis S.A.
PA:ALBPS |
$1.52 Million | €1.30 Million | France | €0.03 | -7.78% | -3.14% | 320.70 Million |
| 1198 |
Curis Inc
NASDAQ:CRIS |
$1.46 Million | $1.46 Million | USA | $0.60 | +9.39% | +50.00% | 12.72 Million |
| 1199 |
Protagenic Therapeutics
NASDAQ:PTIX |
$1.43 Million | $1.43 Million | USA | $0.83 | -4.71% | -17.00% | 510.26K |
| 1200 |
Stayble Therapeutics AB
ST:STABL |
$1.42 Million | Skr13.19 Million | Sweden | Skr0.21 | +0.00% | +0.00% | 148.88 Million |
How Biotechnology Companies Are Ranked by Market Cap
Biotechnology companies are ranked by market cap, the latest share price multiplied by shares outstanding, with each company counted once at its primary listing.
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries